Evidence map›Paper›PMID 31486117›Full record

ArticleBritish journal of clinical pharmacology2019

Biosimilar and interchangeable: Inseparable scientific concepts?

Fernando de Mora, Alejandro Balsa, María Cornide-Santos, Jose-Manuel Carrascosa, Sara Marsal, Javier P Gisbert, Miguel-Angel Abad, Rafael F Duarte, Michael Wiechmann, Rafael Martínez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Biosimilar and interchangeable: Inseparable scientific concepts?British journal of clinical pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fernando de MoraDepartment of Pharmacology, Therapeutics and Toxicology, Universidad Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-3002-6004
Alejandro BalsaHospital La paz, Rheumatology Unit, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain.ORCID 0000-0001-8070-7062
María Cornide-SantosMedical Oncology, Hospital General de Segovia, Segovia, Spain.
Jose-Manuel CarrascosaDermatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.ORCID 0000-0003-4266-0771
Sara MarsalRheumatology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Javier P GisbertGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.ORCID 0000-0003-2090-3445
Miguel-Angel AbadFEA Reumatología, Hospital Virgen del Puerto, Plasencia, Spain.
Rafael F DuarteHematology Department, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.
Michael WiechmannGlobal Medical Affairs, Sandoz  Biopharmaceutical, Holzkirchen, Germany.
Rafael MartínezMedical Affairs Department, Sandoz Iberia, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug SubstitutionBiosimilar PharmaceuticalsClinical Trials as TopicHumansTerminology as TopicTreatment OutcomeBiosimilar Pharmaceuticalsbiologicalbiosimilarbiosimilarityinterchangeabilityinterchangeableswitch

Identifiers

PMID31486117
PMCPMC6848899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.